SlideShare ist ein Scribd-Unternehmen logo
1 von 24
Occupational cancer :
identifying the culprits
John Cherrie

INSTITUTE OF OCCUPATIONAL MEDICINE . Edinburgh . UK

www.iom-world.org
Summary…
•
•
•

•
•

Current occupational cancer burden in
Great Britain
What are the main causes identified in this
work and how many people are affected?
What substances can we reasonably ignore
as part of this initiative?
What about the cancer burden in the
future?
Do these data apply elsewhere?
Rushton L, Hutchings SJ, Fortunato L, et al. Occupational cancer burden in
Great Britain. Br J Cancer 2012;107:S3–S7.
Background…
•
•

Over 1 million cancer deaths in Europe each
year and about 5% may be due to work
The commonest cancers are:
•

•
•

•

breast cancer (13.5% of all cancer cases and
29% of cancer cases in women)
colorectal cancers (12.9%) and
lung cancer (12.1%)

Important differences incidence between
countries
•

e.g. about a two fold difference for men between
the highest (Hungary) and the lowest (Bulgaria)
3
The British study…
•

Current Burden of Occupational Cancer:
•
•
•

•

to develop and apply methodology to estimate
current attributable risk, cancer numbers and DALYs
caused by work
to identify important cancer sites
to identify industries and occupations for targeting
for reduction measures

Prediction of Future Burden of Occupational
Cancer:
•
•
•

Estimate size of future burden based on current and
past exposures
Identify cancer sites, carcinogens and industry
sectors where the burden is greatest
Demonstrate effects of measures to reduce exposure
Current Burden Methodology…
• Attributable fraction (AF): the proportion of cases due to
occupation Requires:
•

Risk of Disease (Relative Risk estimates from published
literature)

•

Proportion of Population Exposed (derived from national data
sources, accounting for employment turnover and life
expectancy; adjusted for employment trends)

• Define period of relevant exposure: Risk Exposure Period
(REP) based on cancer latency
• Dose-response risk estimates and proportions ever exposed
over the REP at different exposure levels not generally
available; data therefore obtained for ‘higher’ and ‘lower’
levels
• AFs used to calculate attributable numbers (ANs)
• Estimation for IARC groups 1 (definite) and 2A (probable)
carcinogens and occupational circumstances
Cancer Site

AF (%)
M

F

Deaths (2005)
Total

M

F

Registrations (2004)

Total

M

F

Total

Mesothelioma

97.0

82.5

94.9

1699

238

1937

1699

238

1937

Sinonasal

43.3

19.8

32.7

27

10

38

195

31

126

Lung

21.1

5.3

14.5

4020

725

4745

4627

815

5442

Nasopharynx

10.8

2.4

8.0

7

1

8

14

1

15

Bladder

7.1

1.9

5.3

215

30

245

496

54

550

Breast
NMSC

6.9

4.6
1.1

4.6
4.5

20

555
2

555
23

2513

1969
349

1969
2862

Larynx

2.9

1.6

2.6

17

3

20

50

6

56

Oesophagus

3.3

1.1

2.5

156

28

184

159

29

188

STS
Stomach

3.4
3.0

1.1
0.3

2.4
1.9

11
101

3
6

13
108

22
149

4
9

27
157

NHL
Melanoma
(eye)

2.1
2.9

1.1
0.4

1.7
1.6

43
1

14
0

57
1

102
6

39
1

140
6

9988
(6938,
14794)

3611
(2370,
5412)

13598
(9308,
20206)

Total

8.2
(7.2,
9.9)

2.3 5.3
(1.7, (4.6,
3.2) 6.6)

6355
1655 8010
(5640, (1249, (6888,
7690) 2287) 9977)
Carcinogen or Occupation

Total Registrations
(% of total burden)

Cancer Sites

Asbestos

4216 (30.8%)

Larynx, Lung, Mesothelioma, Stomach

Shift work (+ Flight Personnel)

1957 (14.3%)

Breast

Mineral oils

1730

Bladder, Lung, NMSC, Sinonasal

Solar radiation

1541 (11.3%)

NMSC

Silica

907 (6.6%)

Lung

Diesel engine exhaust

801 (5.9%)

Bladder,Lung

PAHs - Coal tars and pitches

545 (4.0%)

NMSC

Painters

359 (3.2%)

Bladder, Lung, Stomach

Dioxins

316 (2.3%)

Lung, NHL, STS

Environmental Tobacco Smoke
(non-smokers)

284 (2.1%)

Radon

209 (1.5%)

Lung

Welders

175 (1.3%)

Lung, Melanoma (eye)

Tetrachloroethylene

164 (1.2%)

Cervix, NHL, Oesophagus

Arsenic

129 (0.9%)

Lung

Strong inorganic-acid mists

122 (0.9%)

Larynx, Lung

Lung

Chromium

89

Lung, Sinonasal

Non-arsenical insecticides

73

Brain, Leukaemia, Multiple myeloma, NHL
Industry Sector

Attributable Registrations
Male
Female
Total

Exposures

Construction

4573

64

4637

14

Painter + decorators

331

3

334

1

Roadmen + roofers

471

0

471

1

5375

68

5442

16

0

1969

1969

1

1083

169

1252

1

Personal + household services

256

403

659

17

Land Transport

454

42

497

9

Mining

283

12

296

10

Printing, publishing and allied trades

232

50

282

10

Public administration and defence

229

34

263

6

51

136

187

11

Farming

180

39

220

5

Welders

165

16

181

2

Manufacture of instruments, etc

204

2

206

6

Manufacture of transport equipment

164

18

182

16

Non-ferrous metal basic industries

122

34

156

18

Total construction
Shift work (including flight personnel)
Metal workers

Wholesale + retail trades
Predicting Future Burden in
Britain…
•

•

•
•
•
•

AFs estimated for forecast years, e.g. 2010, 2020
… 2060
Define the risk exposure period (REP) for each
year e.g. for 2030, 1981 – 2020 (10-50 years
latency assumed for solid tumours e.g. lung
cancer, 0-20 years for leukaemia)
Some past and some future exposure until 2060
Workers at the beginning (2010) assumed to be
of all working ages
Workers recruited through employment turnover
are assumed to be only aged 15-24
Factors stay the same as 2004/5
Predicting Future Burden in Britain…
•
•

•
•

•

Use 4 levels of exposure
High/Medium/Low/Background
Method effectively shifts the proportion of workers
exposed in different exposure level categories
(H/M/L/B) across time as exposures gradually
decrease
Forecasted numbers take into account employment
turnover and employment trends
Methods applied to top 14 carcinogens/occupations
identified as accounting for 85.7% of total current
(2004) cancer registrations
Forecast GB total cancers (deaths and registrations)
based ONLY on demographic projections (ONS) and
assuming all non-occupational risk
Forecast Risk Exposure Periods – 10-50 year
latency
REPs
‘Known’ exposure

1961-70

1971-80

FTYs
Forecast exposure

1981-90

1991-00

2010

2001-10

2020

2011-20

2030

2021-30

2040

2031-40

2050

2041-50

10 year estimation intervals

REP Risk exposure period
FTY Forecast target year

2060
Change in future exposure:
Scenarios

Estimates made for alternative scenarios of changes
in exposure levels and/or numbers exposed
•

•

•

(1) Baseline scenario - based on pattern of past
exposure, but no future change in exposed
numbers or exposure levels
(2) Baseline trend scenario - based on pattern of
past and current exposure, and on linear
projections up to 20 years into the future, after
which levels assumed constant due to prediction
uncertainty.
(3) ‘Intervention scenarios’ also based on past
and current exposures, and suitably chosen
target exposure levels in the future
Change in future exposure:
Interventions
Can test:
Introduction of a range of possible OELsor
reduction of a current limit
• Improved compliance to an existing exposure
standard
• Planned intervention such as engineering controls
or introduction of personal protective equipment
• Industry closure
Also can vary:
• Timing of introduction (2010, 2020 etc)
• Compliance levels e.g. according to workplace
size (self-employed, 1-49, 50-249, 250+
employees)
•
Forecast lung cancers for
Respirable Crystalline Silica
2010
Attributable
Fraction

3.3

Attributable
registrations

Avoided
registrations

803
2060

Base-line: exposure limit 0.1mg/m3, compliance
33%

1.08

794

Exposure limit 0.05 mg/m3, compliance 33%

0.80

592

202

Exposure limit 0.025 mg/m3, compliance 33%

0.56

409

385

Exposure limit 0.1 mg/m3, compliance 90%

0.14

102

693

Exposure limit 0.05 mg/m3, compliance 90%

0.07

49

745

Exposure limit 0.025 mg/m3, compliance 90%

0.03

21

773
Attributable registrations

A)

B)

1,000

3.0

Attributable Fraction, %

Attributable Registrations

900
800
700
600
500

400
300
200

AFs

2.5

2.0
1.5
1.0
0.5

100
0.0

0

2010

2020

2030

2040

2050

2060

2070

2080

2010 2020 2030 2040 2050 2060 2070 2080

Forecast Year

(1) Baseline: exposure limit 0.1mg/m3 maintained, compliance 33%
(2) Exposure limit 0.05mg/m3 from 2010, compliance 33%
(10) Exposure limit 0.025mg/m3 from 2010, compliance 33%
(11) Exposure limit 0.1mg/m3 maintained, compliance 90%
(12) Exposure limit 0.05mg/m3 from 2010, compliance 90%
(13) Exposure limit 0.025mg/m3 from 2010, compliance 90%

Forecast Year
Improvement in compliance by
workplace size for Silica
2010
Attributable
Fraction %

3.3

Attributable
registrations

Avoided
registrations

803

2060

Base-line: exposure limit 0.1mg/m3, compliance
33%

1.08

794

Exposure limit 0.05mg/m3, compliance 33%

0.80

592

202

Exposure limit 0.05mg/m3, % compliance changes by employed workplace size and
self employed
33% < 250, self employed; 90% 250+

0.68

499

295

33% < 50, self employed; 90% 50+

0.61

451

344

33% self employed; 90% all sizes employed

0.35

261

533

90% all workplaces

0.07

49

745
Attributable Numbers of Cancer Registrations
Scenarios
All

Base (1)

Exposure
Cancer Site
2010
Exposure defined by agent; no appropriate exposure measurements
ETS
Lung
1465
0
Coal tars
Radon
Solar radiation

NMSC
Lung
NMSC

Trend (2)

(3)

(4)

(5)

(6)

2060

0

67

156

489
220
1749
Occupational circumstances, no specified carcinogen
Painters
Bladder, Lung,
461
Stomach

800
379
3069

877
411
3279

602
341
2552

475
317
2030

433
309
1503

402
190
163

640

639

481

383

347

321

Shift work
Welders

3062
140

3848
63

2134
105

1178
83

194
76

0
70

92

47

92

88

87

87

2759

2864

2785

2689

2626

2307

380
837
122

406
794
39

399
442
7

451
102
19

412
49
12

374
21
10

34
10
12

286

123

30

22

8

5

6

139

135

119

123

118

117

119

12050

12327

12938

9812

7944

6064

3705

Breast
Lung

1649
189
Carcinogens for which exposure standards can be set
Arsenic
Lung
128
Asbestos
Larynx, Lung Mesothelioma,
4281
Stomach

Diesel
Silica
Strong acids
TCDD (Dioxins)

Bladder, Lung
Lung
Larynx, Lung
Lung, NHL, STS

Tetrachloroethylene

Cervix, NHL, Oesophagus

Total
Monitoring success…
•

The only practicable approach is to
monitor exposure levels

•

No reduction in cancer levels until 2030 at
earliest (for solid tumours)
After 2030…

•

•

•
•

Use achieved exposed numbers/proportions
exposed at new exposure levels in same
(target setting) forecast model to get achieved
AF
Apply achieved AF to same (2005 based)
cancer projections to get achieved attributable
numbers
Do not apply achieved AF to real 2030 cancer
numbers
Uncertainties and the impact on the
burden estimation
Source of Uncertainty

Potential impact on burden estimate

Exclusion of IARC group 2B and unknown
carcinogens e.g. for electrical workers and
leukaemia

↓

Inappropriate choice of source study for risk
estimate
Imprecision in source risk estimate

↑↓

Source risk estimate from study of highly exposed
workers applied to lower exposed target population

↑

Risk estimate biased down by healthy worker effect,
exposure misclassification in both study and
reference population

↓

Inaccurate latency/risk exposure period, e.g. most
recent 20 years used for leukaemia, up to 50 years
solid tumours

↓

Effect of unmeasured confounders
Unknown proportion exposed at different levels

↑↓

↑↓
↑↓
Cancer burden elsewhere…
•

China

Li P, Deng S-S, Wang J-B, et al. Occupational and environmental cancer incidence and
mortality in China. Occup Med (Lond) Published Online First: 12 March 2012.
doi:10.1093/occmed/kqs016
Mesothelioma mortality rate

Delgermaa V, Takahashi K, Park E-K, et al. Global mesothelioma deaths reported to the World
Health Organization between 1994 and 2008. Bull World Health Organ 2011;89:716–724C.
Summary…
•
•
•
•
•
•
•

Currently about 8,000 deaths and 14,000 cancer
cases due to past work in Britain
Most deaths from lung cancer, mesothelioma and
breast cancer
Most deaths associated with the construction
industry
Future burden could be much lower with
appropriate interventions
Respirable crystalline silica – we need better
compliance (and a lower limit)
Best interventions differ by agent
Monitoring exposure is the best way to track
progress

Weitere ähnliche Inhalte

Was ist angesagt?

The Historical hygiene assessment of National Semiconductor UK
The Historical hygiene assessment of National Semiconductor UKThe Historical hygiene assessment of National Semiconductor UK
The Historical hygiene assessment of National Semiconductor UKRetired
 
CANCER IN COMMUNITY HEALTH NURSING ppt
CANCER IN COMMUNITY HEALTH NURSING pptCANCER IN COMMUNITY HEALTH NURSING ppt
CANCER IN COMMUNITY HEALTH NURSING pptHarsh Rastogi
 
Epidemiology of cancer
Epidemiology of cancerEpidemiology of cancer
Epidemiology of cancerDOCTOR WHO
 
IRJET- Lung Cancer Detection using Digital Image Processing and Artificia...
IRJET-  	  Lung Cancer Detection using Digital Image Processing and Artificia...IRJET-  	  Lung Cancer Detection using Digital Image Processing and Artificia...
IRJET- Lung Cancer Detection using Digital Image Processing and Artificia...IRJET Journal
 
Introduction to cancer epidemiology basics mr es021012
Introduction to cancer epidemiology basics mr es021012Introduction to cancer epidemiology basics mr es021012
Introduction to cancer epidemiology basics mr es021012Portobellochris
 
Cancer epidemiology
Cancer epidemiologyCancer epidemiology
Cancer epidemiologyNayyar Kazmi
 
IRJET- A Review of Lung Cancer Detection and Segmentation on CT Scan
IRJET- A Review of Lung Cancer Detection and Segmentation on CT ScanIRJET- A Review of Lung Cancer Detection and Segmentation on CT Scan
IRJET- A Review of Lung Cancer Detection and Segmentation on CT ScanIRJET Journal
 
Epidemiology of cancer
Epidemiology of cancer Epidemiology of cancer
Epidemiology of cancer suhas k r
 
Innovations conference 2014 md hamidul huque population based assessment of...
Innovations conference 2014   md hamidul huque population based assessment of...Innovations conference 2014   md hamidul huque population based assessment of...
Innovations conference 2014 md hamidul huque population based assessment of...Cancer Institute NSW
 
Cancer Gdsj091 Final
Cancer Gdsj091 FinalCancer Gdsj091 Final
Cancer Gdsj091 FinalAndrew Kwami
 
Case Study for ARI - Monochromatic X-Rays
Case Study for ARI - Monochromatic X-RaysCase Study for ARI - Monochromatic X-Rays
Case Study for ARI - Monochromatic X-RaysAleksey Dubrovensky
 
21 years of reasearch on hifu on breast
21 years of reasearch on hifu on breast21 years of reasearch on hifu on breast
21 years of reasearch on hifu on breastGulbaz Saiyad
 
Examenes radiologicos y riesgo de cancer en pacientes
Examenes radiologicos y riesgo  de cancer  en pacientesExamenes radiologicos y riesgo  de cancer  en pacientes
Examenes radiologicos y riesgo de cancer en pacientesJesús Aponte Ortiz
 
Breast cancer radioimmunoscintigraphy
Breast cancer  radioimmunoscintigraphyBreast cancer  radioimmunoscintigraphy
Breast cancer radioimmunoscintigraphyfatmahoceny
 
Cancer-Diagnosis-and-Therapy-Congress-17June
Cancer-Diagnosis-and-Therapy-Congress-17JuneCancer-Diagnosis-and-Therapy-Congress-17June
Cancer-Diagnosis-and-Therapy-Congress-17JuneGianni Mura
 
Levels of Dichlorodiphenyltrichloroethane (DDT) and Hexachlorocyclohexane (HC...
Levels of Dichlorodiphenyltrichloroethane (DDT) and Hexachlorocyclohexane (HC...Levels of Dichlorodiphenyltrichloroethane (DDT) and Hexachlorocyclohexane (HC...
Levels of Dichlorodiphenyltrichloroethane (DDT) and Hexachlorocyclohexane (HC...Premier Publishers
 

Was ist angesagt? (20)

The Historical hygiene assessment of National Semiconductor UK
The Historical hygiene assessment of National Semiconductor UKThe Historical hygiene assessment of National Semiconductor UK
The Historical hygiene assessment of National Semiconductor UK
 
K1 K. Straif
K1 K. StraifK1 K. Straif
K1 K. Straif
 
CANCER IN COMMUNITY HEALTH NURSING ppt
CANCER IN COMMUNITY HEALTH NURSING pptCANCER IN COMMUNITY HEALTH NURSING ppt
CANCER IN COMMUNITY HEALTH NURSING ppt
 
Epidemiology of cancer
Epidemiology of cancerEpidemiology of cancer
Epidemiology of cancer
 
Epidemiology of cancer
Epidemiology of cancerEpidemiology of cancer
Epidemiology of cancer
 
IRJET- Lung Cancer Detection using Digital Image Processing and Artificia...
IRJET-  	  Lung Cancer Detection using Digital Image Processing and Artificia...IRJET-  	  Lung Cancer Detection using Digital Image Processing and Artificia...
IRJET- Lung Cancer Detection using Digital Image Processing and Artificia...
 
Introduction to cancer epidemiology basics mr es021012
Introduction to cancer epidemiology basics mr es021012Introduction to cancer epidemiology basics mr es021012
Introduction to cancer epidemiology basics mr es021012
 
Cancer epidemiology
Cancer epidemiologyCancer epidemiology
Cancer epidemiology
 
IRJET- A Review of Lung Cancer Detection and Segmentation on CT Scan
IRJET- A Review of Lung Cancer Detection and Segmentation on CT ScanIRJET- A Review of Lung Cancer Detection and Segmentation on CT Scan
IRJET- A Review of Lung Cancer Detection and Segmentation on CT Scan
 
Epidemiology of cancer
Epidemiology of cancer Epidemiology of cancer
Epidemiology of cancer
 
Innovations conference 2014 md hamidul huque population based assessment of...
Innovations conference 2014   md hamidul huque population based assessment of...Innovations conference 2014   md hamidul huque population based assessment of...
Innovations conference 2014 md hamidul huque population based assessment of...
 
Cancer Gdsj091 Final
Cancer Gdsj091 FinalCancer Gdsj091 Final
Cancer Gdsj091 Final
 
Case Study for ARI - Monochromatic X-Rays
Case Study for ARI - Monochromatic X-RaysCase Study for ARI - Monochromatic X-Rays
Case Study for ARI - Monochromatic X-Rays
 
21 years of reasearch on hifu on breast
21 years of reasearch on hifu on breast21 years of reasearch on hifu on breast
21 years of reasearch on hifu on breast
 
Examenes radiologicos y riesgo de cancer en pacientes
Examenes radiologicos y riesgo  de cancer  en pacientesExamenes radiologicos y riesgo  de cancer  en pacientes
Examenes radiologicos y riesgo de cancer en pacientes
 
Breast cancer radioimmunoscintigraphy
Breast cancer  radioimmunoscintigraphyBreast cancer  radioimmunoscintigraphy
Breast cancer radioimmunoscintigraphy
 
Cancer-Diagnosis-and-Therapy-Congress-17June
Cancer-Diagnosis-and-Therapy-Congress-17JuneCancer-Diagnosis-and-Therapy-Congress-17June
Cancer-Diagnosis-and-Therapy-Congress-17June
 
J1036471
J1036471J1036471
J1036471
 
Levels of Dichlorodiphenyltrichloroethane (DDT) and Hexachlorocyclohexane (HC...
Levels of Dichlorodiphenyltrichloroethane (DDT) and Hexachlorocyclohexane (HC...Levels of Dichlorodiphenyltrichloroethane (DDT) and Hexachlorocyclohexane (HC...
Levels of Dichlorodiphenyltrichloroethane (DDT) and Hexachlorocyclohexane (HC...
 
Muzammil
MuzammilMuzammil
Muzammil
 

Ähnlich wie 3. Occupational cancer burden identifying the main culprits

What should we be doing to prevent occupational diseases from hazardous subst...
What should we be doing to prevent occupational diseases from hazardous subst...What should we be doing to prevent occupational diseases from hazardous subst...
What should we be doing to prevent occupational diseases from hazardous subst...Retired
 
Eliminating occupational cancer
Eliminating occupational cancerEliminating occupational cancer
Eliminating occupational cancerRetired
 
Epidemiology and trends of asbestos-related diseases at Helsinki Asbestos 2014
Epidemiology and trends of asbestos-related diseases at Helsinki Asbestos 2014Epidemiology and trends of asbestos-related diseases at Helsinki Asbestos 2014
Epidemiology and trends of asbestos-related diseases at Helsinki Asbestos 2014Työterveyslaitos
 
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)European School of Oncology
 
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)European School of Oncology
 
Stage 3 colon cancer
Stage 3 colon cancerStage 3 colon cancer
Stage 3 colon cancerspa718
 
Radiation therapy for early breast cancer bgicc 2015
Radiation therapy for early breast cancer bgicc 2015Radiation therapy for early breast cancer bgicc 2015
Radiation therapy for early breast cancer bgicc 2015Mohamed Abdulla
 
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...OSUCCC - James
 
Updating the european carcinogens directive
Updating the european carcinogens directiveUpdating the european carcinogens directive
Updating the european carcinogens directiveRetired
 
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...Jukka Takala
 
Health Surveillance of asbestos-exposed workers at Helsinki Asbestos 2014
Health Surveillance of asbestos-exposed workers at Helsinki Asbestos 2014Health Surveillance of asbestos-exposed workers at Helsinki Asbestos 2014
Health Surveillance of asbestos-exposed workers at Helsinki Asbestos 2014Työterveyslaitos
 
Implementing prevention AYA survivors
Implementing prevention AYA survivorsImplementing prevention AYA survivors
Implementing prevention AYA survivorsGraham Colditz
 
Implementation of an audit and dose reduction program for ct matyagin
Implementation of an audit and dose reduction program for ct matyaginImplementation of an audit and dose reduction program for ct matyagin
Implementation of an audit and dose reduction program for ct matyaginLeishman Associates
 
Overview of occupational radiation safety in hospital, Dr. Avinash u. Sonaware
Overview of occupational radiation safety in hospital, Dr. Avinash u. SonawareOverview of occupational radiation safety in hospital, Dr. Avinash u. Sonaware
Overview of occupational radiation safety in hospital, Dr. Avinash u. Sonawareohscmcvellore
 
Room 11B_ Session name_1715_Ogbudu.pptx
Room 11B_ Session name_1715_Ogbudu.pptxRoom 11B_ Session name_1715_Ogbudu.pptx
Room 11B_ Session name_1715_Ogbudu.pptxhenrypat2
 

Ähnlich wie 3. Occupational cancer burden identifying the main culprits (20)

What should we be doing to prevent occupational diseases from hazardous subst...
What should we be doing to prevent occupational diseases from hazardous subst...What should we be doing to prevent occupational diseases from hazardous subst...
What should we be doing to prevent occupational diseases from hazardous subst...
 
Eliminating occupational cancer
Eliminating occupational cancerEliminating occupational cancer
Eliminating occupational cancer
 
Epidemiology and trends of asbestos-related diseases at Helsinki Asbestos 2014
Epidemiology and trends of asbestos-related diseases at Helsinki Asbestos 2014Epidemiology and trends of asbestos-related diseases at Helsinki Asbestos 2014
Epidemiology and trends of asbestos-related diseases at Helsinki Asbestos 2014
 
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
 
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
 
Stage 3 colon cancer
Stage 3 colon cancerStage 3 colon cancer
Stage 3 colon cancer
 
Radiation therapy for early breast cancer bgicc 2015
Radiation therapy for early breast cancer bgicc 2015Radiation therapy for early breast cancer bgicc 2015
Radiation therapy for early breast cancer bgicc 2015
 
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
 
Updating the european carcinogens directive
Updating the european carcinogens directiveUpdating the european carcinogens directive
Updating the european carcinogens directive
 
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
 
Health Surveillance of asbestos-exposed workers at Helsinki Asbestos 2014
Health Surveillance of asbestos-exposed workers at Helsinki Asbestos 2014Health Surveillance of asbestos-exposed workers at Helsinki Asbestos 2014
Health Surveillance of asbestos-exposed workers at Helsinki Asbestos 2014
 
Sbs
SbsSbs
Sbs
 
Hssh0910
Hssh0910Hssh0910
Hssh0910
 
Implementing prevention AYA survivors
Implementing prevention AYA survivorsImplementing prevention AYA survivors
Implementing prevention AYA survivors
 
Implementation of an audit and dose reduction program for ct matyagin
Implementation of an audit and dose reduction program for ct matyaginImplementation of an audit and dose reduction program for ct matyagin
Implementation of an audit and dose reduction program for ct matyagin
 
BALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
BALKAN MCO 2011 - E. Vrdoljak - RadiotherapyBALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
BALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
 
Overview of occupational radiation safety in hospital, Dr. Avinash u. Sonaware
Overview of occupational radiation safety in hospital, Dr. Avinash u. SonawareOverview of occupational radiation safety in hospital, Dr. Avinash u. Sonaware
Overview of occupational radiation safety in hospital, Dr. Avinash u. Sonaware
 
Sbs
SbsSbs
Sbs
 
Wolin opac2013
Wolin opac2013Wolin opac2013
Wolin opac2013
 
Room 11B_ Session name_1715_Ogbudu.pptx
Room 11B_ Session name_1715_Ogbudu.pptxRoom 11B_ Session name_1715_Ogbudu.pptx
Room 11B_ Session name_1715_Ogbudu.pptx
 

Mehr von Retired

Occupational health and hygiene research: A talk at the Scottish Parliament
Occupational health and hygiene research: A talk at the Scottish ParliamentOccupational health and hygiene research: A talk at the Scottish Parliament
Occupational health and hygiene research: A talk at the Scottish ParliamentRetired
 
Dermal exposure science: it’s not skin-deep
Dermal exposure science: it’s not skin-deep Dermal exposure science: it’s not skin-deep
Dermal exposure science: it’s not skin-deep Retired
 
Jim Vincent and inhalable dust
Jim Vincent and inhalable dustJim Vincent and inhalable dust
Jim Vincent and inhalable dustRetired
 
A holistic approach to managing workplace exposure to solar UV
A holistic approach to managing workplace exposure to solar UVA holistic approach to managing workplace exposure to solar UV
A holistic approach to managing workplace exposure to solar UVRetired
 
Keynote presentation on Current and Future Trends in Exposure Science
Keynote presentation on Current and Future Trends in Exposure Science Keynote presentation on Current and Future Trends in Exposure Science
Keynote presentation on Current and Future Trends in Exposure Science Retired
 
Exposure assessment for occupational epidemiology part 2
Exposure assessment for occupational epidemiology part 2Exposure assessment for occupational epidemiology part 2
Exposure assessment for occupational epidemiology part 2Retired
 
Exposure assessment for occupational epidemiology part 1
Exposure assessment for occupational epidemiology part 1Exposure assessment for occupational epidemiology part 1
Exposure assessment for occupational epidemiology part 1Retired
 
The exposome and work
The exposome and workThe exposome and work
The exposome and workRetired
 
Control banding and beyond
Control banding and beyondControl banding and beyond
Control banding and beyondRetired
 
Exposure assessment for epidemiology
Exposure assessment for epidemiologyExposure assessment for epidemiology
Exposure assessment for epidemiologyRetired
 
What's the point of occupational exposure limits
What's the point of occupational exposure limitsWhat's the point of occupational exposure limits
What's the point of occupational exposure limitsRetired
 
Interpretation of dermal exposure measurements and model outputs
Interpretation of dermal exposure measurements and model outputsInterpretation of dermal exposure measurements and model outputs
Interpretation of dermal exposure measurements and model outputsRetired
 
Modelling dermal exposure
Modelling dermal exposureModelling dermal exposure
Modelling dermal exposureRetired
 
Measurement of dermal exposure - principles and methods
Measurement of dermal exposure - principles and methodsMeasurement of dermal exposure - principles and methods
Measurement of dermal exposure - principles and methodsRetired
 
Why is dermal exposure important?
Why is dermal exposure important?Why is dermal exposure important?
Why is dermal exposure important?Retired
 
Skin exposure modelling and measurement - introduction
Skin exposure modelling and measurement - introductionSkin exposure modelling and measurement - introduction
Skin exposure modelling and measurement - introductionRetired
 
Use of sensors in occupational exposure assessment
Use of sensors in occupational exposure assessment Use of sensors in occupational exposure assessment
Use of sensors in occupational exposure assessment Retired
 
8. IOHA - where is it all going
8. IOHA - where is it all going 8. IOHA - where is it all going
8. IOHA - where is it all going Retired
 
7. IOHA - the occupational exposome
7. IOHA -  the occupational exposome7. IOHA -  the occupational exposome
7. IOHA - the occupational exposomeRetired
 

Mehr von Retired (20)

Occupational health and hygiene research: A talk at the Scottish Parliament
Occupational health and hygiene research: A talk at the Scottish ParliamentOccupational health and hygiene research: A talk at the Scottish Parliament
Occupational health and hygiene research: A talk at the Scottish Parliament
 
Dermal exposure science: it’s not skin-deep
Dermal exposure science: it’s not skin-deep Dermal exposure science: it’s not skin-deep
Dermal exposure science: it’s not skin-deep
 
Jim Vincent and inhalable dust
Jim Vincent and inhalable dustJim Vincent and inhalable dust
Jim Vincent and inhalable dust
 
24,869
24,86924,869
24,869
 
A holistic approach to managing workplace exposure to solar UV
A holistic approach to managing workplace exposure to solar UVA holistic approach to managing workplace exposure to solar UV
A holistic approach to managing workplace exposure to solar UV
 
Keynote presentation on Current and Future Trends in Exposure Science
Keynote presentation on Current and Future Trends in Exposure Science Keynote presentation on Current and Future Trends in Exposure Science
Keynote presentation on Current and Future Trends in Exposure Science
 
Exposure assessment for occupational epidemiology part 2
Exposure assessment for occupational epidemiology part 2Exposure assessment for occupational epidemiology part 2
Exposure assessment for occupational epidemiology part 2
 
Exposure assessment for occupational epidemiology part 1
Exposure assessment for occupational epidemiology part 1Exposure assessment for occupational epidemiology part 1
Exposure assessment for occupational epidemiology part 1
 
The exposome and work
The exposome and workThe exposome and work
The exposome and work
 
Control banding and beyond
Control banding and beyondControl banding and beyond
Control banding and beyond
 
Exposure assessment for epidemiology
Exposure assessment for epidemiologyExposure assessment for epidemiology
Exposure assessment for epidemiology
 
What's the point of occupational exposure limits
What's the point of occupational exposure limitsWhat's the point of occupational exposure limits
What's the point of occupational exposure limits
 
Interpretation of dermal exposure measurements and model outputs
Interpretation of dermal exposure measurements and model outputsInterpretation of dermal exposure measurements and model outputs
Interpretation of dermal exposure measurements and model outputs
 
Modelling dermal exposure
Modelling dermal exposureModelling dermal exposure
Modelling dermal exposure
 
Measurement of dermal exposure - principles and methods
Measurement of dermal exposure - principles and methodsMeasurement of dermal exposure - principles and methods
Measurement of dermal exposure - principles and methods
 
Why is dermal exposure important?
Why is dermal exposure important?Why is dermal exposure important?
Why is dermal exposure important?
 
Skin exposure modelling and measurement - introduction
Skin exposure modelling and measurement - introductionSkin exposure modelling and measurement - introduction
Skin exposure modelling and measurement - introduction
 
Use of sensors in occupational exposure assessment
Use of sensors in occupational exposure assessment Use of sensors in occupational exposure assessment
Use of sensors in occupational exposure assessment
 
8. IOHA - where is it all going
8. IOHA - where is it all going 8. IOHA - where is it all going
8. IOHA - where is it all going
 
7. IOHA - the occupational exposome
7. IOHA -  the occupational exposome7. IOHA -  the occupational exposome
7. IOHA - the occupational exposome
 

Kürzlich hochgeladen

Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service Available
Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service AvailableCall Girls Jaipur Just Call 9521753030 Top Class Call Girl Service Available
Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service AvailableJanvi Singh
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableGENUINE ESCORT AGENCY
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...Sheetaleventcompany
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...tanya dube
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Anamika Rawat
 
Andheri East ^ (Genuine) Escort Service Mumbai ₹7.5k Pick Up & Drop With Cash...
Andheri East ^ (Genuine) Escort Service Mumbai ₹7.5k Pick Up & Drop With Cash...Andheri East ^ (Genuine) Escort Service Mumbai ₹7.5k Pick Up & Drop With Cash...
Andheri East ^ (Genuine) Escort Service Mumbai ₹7.5k Pick Up & Drop With Cash...Anamika Rawat
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Sheetaleventcompany
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...chetankumar9855
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...parulsinha
 
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Mysore Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mysore Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Mysore Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mysore Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Ishani Gupta
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...mahaiklolahd
 
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Availableperfect solution
 
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...karishmasinghjnh
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Anamika Rawat
 
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...BhumiSaxena1
 

Kürzlich hochgeladen (20)

Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service Available
Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service AvailableCall Girls Jaipur Just Call 9521753030 Top Class Call Girl Service Available
Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service Available
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
 
Andheri East ^ (Genuine) Escort Service Mumbai ₹7.5k Pick Up & Drop With Cash...
Andheri East ^ (Genuine) Escort Service Mumbai ₹7.5k Pick Up & Drop With Cash...Andheri East ^ (Genuine) Escort Service Mumbai ₹7.5k Pick Up & Drop With Cash...
Andheri East ^ (Genuine) Escort Service Mumbai ₹7.5k Pick Up & Drop With Cash...
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
 
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
 
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
 
Call Girls Mysore Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mysore Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Mysore Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mysore Just Call 8250077686 Top Class Call Girl Service Available
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
 
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
 
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
 
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
 
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
 

3. Occupational cancer burden identifying the main culprits

  • 1. Occupational cancer : identifying the culprits John Cherrie INSTITUTE OF OCCUPATIONAL MEDICINE . Edinburgh . UK www.iom-world.org
  • 2. Summary… • • • • • Current occupational cancer burden in Great Britain What are the main causes identified in this work and how many people are affected? What substances can we reasonably ignore as part of this initiative? What about the cancer burden in the future? Do these data apply elsewhere? Rushton L, Hutchings SJ, Fortunato L, et al. Occupational cancer burden in Great Britain. Br J Cancer 2012;107:S3–S7.
  • 3. Background… • • Over 1 million cancer deaths in Europe each year and about 5% may be due to work The commonest cancers are: • • • • breast cancer (13.5% of all cancer cases and 29% of cancer cases in women) colorectal cancers (12.9%) and lung cancer (12.1%) Important differences incidence between countries • e.g. about a two fold difference for men between the highest (Hungary) and the lowest (Bulgaria) 3
  • 4. The British study… • Current Burden of Occupational Cancer: • • • • to develop and apply methodology to estimate current attributable risk, cancer numbers and DALYs caused by work to identify important cancer sites to identify industries and occupations for targeting for reduction measures Prediction of Future Burden of Occupational Cancer: • • • Estimate size of future burden based on current and past exposures Identify cancer sites, carcinogens and industry sectors where the burden is greatest Demonstrate effects of measures to reduce exposure
  • 5. Current Burden Methodology… • Attributable fraction (AF): the proportion of cases due to occupation Requires: • Risk of Disease (Relative Risk estimates from published literature) • Proportion of Population Exposed (derived from national data sources, accounting for employment turnover and life expectancy; adjusted for employment trends) • Define period of relevant exposure: Risk Exposure Period (REP) based on cancer latency • Dose-response risk estimates and proportions ever exposed over the REP at different exposure levels not generally available; data therefore obtained for ‘higher’ and ‘lower’ levels • AFs used to calculate attributable numbers (ANs) • Estimation for IARC groups 1 (definite) and 2A (probable) carcinogens and occupational circumstances
  • 6. Cancer Site AF (%) M F Deaths (2005) Total M F Registrations (2004) Total M F Total Mesothelioma 97.0 82.5 94.9 1699 238 1937 1699 238 1937 Sinonasal 43.3 19.8 32.7 27 10 38 195 31 126 Lung 21.1 5.3 14.5 4020 725 4745 4627 815 5442 Nasopharynx 10.8 2.4 8.0 7 1 8 14 1 15 Bladder 7.1 1.9 5.3 215 30 245 496 54 550 Breast NMSC 6.9 4.6 1.1 4.6 4.5 20 555 2 555 23 2513 1969 349 1969 2862 Larynx 2.9 1.6 2.6 17 3 20 50 6 56 Oesophagus 3.3 1.1 2.5 156 28 184 159 29 188 STS Stomach 3.4 3.0 1.1 0.3 2.4 1.9 11 101 3 6 13 108 22 149 4 9 27 157 NHL Melanoma (eye) 2.1 2.9 1.1 0.4 1.7 1.6 43 1 14 0 57 1 102 6 39 1 140 6 9988 (6938, 14794) 3611 (2370, 5412) 13598 (9308, 20206) Total 8.2 (7.2, 9.9) 2.3 5.3 (1.7, (4.6, 3.2) 6.6) 6355 1655 8010 (5640, (1249, (6888, 7690) 2287) 9977)
  • 7.
  • 8.
  • 9. Carcinogen or Occupation Total Registrations (% of total burden) Cancer Sites Asbestos 4216 (30.8%) Larynx, Lung, Mesothelioma, Stomach Shift work (+ Flight Personnel) 1957 (14.3%) Breast Mineral oils 1730 Bladder, Lung, NMSC, Sinonasal Solar radiation 1541 (11.3%) NMSC Silica 907 (6.6%) Lung Diesel engine exhaust 801 (5.9%) Bladder,Lung PAHs - Coal tars and pitches 545 (4.0%) NMSC Painters 359 (3.2%) Bladder, Lung, Stomach Dioxins 316 (2.3%) Lung, NHL, STS Environmental Tobacco Smoke (non-smokers) 284 (2.1%) Radon 209 (1.5%) Lung Welders 175 (1.3%) Lung, Melanoma (eye) Tetrachloroethylene 164 (1.2%) Cervix, NHL, Oesophagus Arsenic 129 (0.9%) Lung Strong inorganic-acid mists 122 (0.9%) Larynx, Lung Lung Chromium 89 Lung, Sinonasal Non-arsenical insecticides 73 Brain, Leukaemia, Multiple myeloma, NHL
  • 10. Industry Sector Attributable Registrations Male Female Total Exposures Construction 4573 64 4637 14 Painter + decorators 331 3 334 1 Roadmen + roofers 471 0 471 1 5375 68 5442 16 0 1969 1969 1 1083 169 1252 1 Personal + household services 256 403 659 17 Land Transport 454 42 497 9 Mining 283 12 296 10 Printing, publishing and allied trades 232 50 282 10 Public administration and defence 229 34 263 6 51 136 187 11 Farming 180 39 220 5 Welders 165 16 181 2 Manufacture of instruments, etc 204 2 206 6 Manufacture of transport equipment 164 18 182 16 Non-ferrous metal basic industries 122 34 156 18 Total construction Shift work (including flight personnel) Metal workers Wholesale + retail trades
  • 11. Predicting Future Burden in Britain… • • • • • • AFs estimated for forecast years, e.g. 2010, 2020 … 2060 Define the risk exposure period (REP) for each year e.g. for 2030, 1981 – 2020 (10-50 years latency assumed for solid tumours e.g. lung cancer, 0-20 years for leukaemia) Some past and some future exposure until 2060 Workers at the beginning (2010) assumed to be of all working ages Workers recruited through employment turnover are assumed to be only aged 15-24 Factors stay the same as 2004/5
  • 12. Predicting Future Burden in Britain… • • • • • Use 4 levels of exposure High/Medium/Low/Background Method effectively shifts the proportion of workers exposed in different exposure level categories (H/M/L/B) across time as exposures gradually decrease Forecasted numbers take into account employment turnover and employment trends Methods applied to top 14 carcinogens/occupations identified as accounting for 85.7% of total current (2004) cancer registrations Forecast GB total cancers (deaths and registrations) based ONLY on demographic projections (ONS) and assuming all non-occupational risk
  • 13. Forecast Risk Exposure Periods – 10-50 year latency REPs ‘Known’ exposure 1961-70 1971-80 FTYs Forecast exposure 1981-90 1991-00 2010 2001-10 2020 2011-20 2030 2021-30 2040 2031-40 2050 2041-50 10 year estimation intervals REP Risk exposure period FTY Forecast target year 2060
  • 14. Change in future exposure: Scenarios Estimates made for alternative scenarios of changes in exposure levels and/or numbers exposed • • • (1) Baseline scenario - based on pattern of past exposure, but no future change in exposed numbers or exposure levels (2) Baseline trend scenario - based on pattern of past and current exposure, and on linear projections up to 20 years into the future, after which levels assumed constant due to prediction uncertainty. (3) ‘Intervention scenarios’ also based on past and current exposures, and suitably chosen target exposure levels in the future
  • 15. Change in future exposure: Interventions Can test: Introduction of a range of possible OELsor reduction of a current limit • Improved compliance to an existing exposure standard • Planned intervention such as engineering controls or introduction of personal protective equipment • Industry closure Also can vary: • Timing of introduction (2010, 2020 etc) • Compliance levels e.g. according to workplace size (self-employed, 1-49, 50-249, 250+ employees) •
  • 16. Forecast lung cancers for Respirable Crystalline Silica 2010 Attributable Fraction 3.3 Attributable registrations Avoided registrations 803 2060 Base-line: exposure limit 0.1mg/m3, compliance 33% 1.08 794 Exposure limit 0.05 mg/m3, compliance 33% 0.80 592 202 Exposure limit 0.025 mg/m3, compliance 33% 0.56 409 385 Exposure limit 0.1 mg/m3, compliance 90% 0.14 102 693 Exposure limit 0.05 mg/m3, compliance 90% 0.07 49 745 Exposure limit 0.025 mg/m3, compliance 90% 0.03 21 773
  • 17. Attributable registrations A) B) 1,000 3.0 Attributable Fraction, % Attributable Registrations 900 800 700 600 500 400 300 200 AFs 2.5 2.0 1.5 1.0 0.5 100 0.0 0 2010 2020 2030 2040 2050 2060 2070 2080 2010 2020 2030 2040 2050 2060 2070 2080 Forecast Year (1) Baseline: exposure limit 0.1mg/m3 maintained, compliance 33% (2) Exposure limit 0.05mg/m3 from 2010, compliance 33% (10) Exposure limit 0.025mg/m3 from 2010, compliance 33% (11) Exposure limit 0.1mg/m3 maintained, compliance 90% (12) Exposure limit 0.05mg/m3 from 2010, compliance 90% (13) Exposure limit 0.025mg/m3 from 2010, compliance 90% Forecast Year
  • 18. Improvement in compliance by workplace size for Silica 2010 Attributable Fraction % 3.3 Attributable registrations Avoided registrations 803 2060 Base-line: exposure limit 0.1mg/m3, compliance 33% 1.08 794 Exposure limit 0.05mg/m3, compliance 33% 0.80 592 202 Exposure limit 0.05mg/m3, % compliance changes by employed workplace size and self employed 33% < 250, self employed; 90% 250+ 0.68 499 295 33% < 50, self employed; 90% 50+ 0.61 451 344 33% self employed; 90% all sizes employed 0.35 261 533 90% all workplaces 0.07 49 745
  • 19. Attributable Numbers of Cancer Registrations Scenarios All Base (1) Exposure Cancer Site 2010 Exposure defined by agent; no appropriate exposure measurements ETS Lung 1465 0 Coal tars Radon Solar radiation NMSC Lung NMSC Trend (2) (3) (4) (5) (6) 2060 0 67 156 489 220 1749 Occupational circumstances, no specified carcinogen Painters Bladder, Lung, 461 Stomach 800 379 3069 877 411 3279 602 341 2552 475 317 2030 433 309 1503 402 190 163 640 639 481 383 347 321 Shift work Welders 3062 140 3848 63 2134 105 1178 83 194 76 0 70 92 47 92 88 87 87 2759 2864 2785 2689 2626 2307 380 837 122 406 794 39 399 442 7 451 102 19 412 49 12 374 21 10 34 10 12 286 123 30 22 8 5 6 139 135 119 123 118 117 119 12050 12327 12938 9812 7944 6064 3705 Breast Lung 1649 189 Carcinogens for which exposure standards can be set Arsenic Lung 128 Asbestos Larynx, Lung Mesothelioma, 4281 Stomach Diesel Silica Strong acids TCDD (Dioxins) Bladder, Lung Lung Larynx, Lung Lung, NHL, STS Tetrachloroethylene Cervix, NHL, Oesophagus Total
  • 20. Monitoring success… • The only practicable approach is to monitor exposure levels • No reduction in cancer levels until 2030 at earliest (for solid tumours) After 2030… • • • • Use achieved exposed numbers/proportions exposed at new exposure levels in same (target setting) forecast model to get achieved AF Apply achieved AF to same (2005 based) cancer projections to get achieved attributable numbers Do not apply achieved AF to real 2030 cancer numbers
  • 21. Uncertainties and the impact on the burden estimation Source of Uncertainty Potential impact on burden estimate Exclusion of IARC group 2B and unknown carcinogens e.g. for electrical workers and leukaemia ↓ Inappropriate choice of source study for risk estimate Imprecision in source risk estimate ↑↓ Source risk estimate from study of highly exposed workers applied to lower exposed target population ↑ Risk estimate biased down by healthy worker effect, exposure misclassification in both study and reference population ↓ Inaccurate latency/risk exposure period, e.g. most recent 20 years used for leukaemia, up to 50 years solid tumours ↓ Effect of unmeasured confounders Unknown proportion exposed at different levels ↑↓ ↑↓ ↑↓
  • 22. Cancer burden elsewhere… • China Li P, Deng S-S, Wang J-B, et al. Occupational and environmental cancer incidence and mortality in China. Occup Med (Lond) Published Online First: 12 March 2012. doi:10.1093/occmed/kqs016
  • 23. Mesothelioma mortality rate Delgermaa V, Takahashi K, Park E-K, et al. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 2011;89:716–724C.
  • 24. Summary… • • • • • • • Currently about 8,000 deaths and 14,000 cancer cases due to past work in Britain Most deaths from lung cancer, mesothelioma and breast cancer Most deaths associated with the construction industry Future burden could be much lower with appropriate interventions Respirable crystalline silica – we need better compliance (and a lower limit) Best interventions differ by agent Monitoring exposure is the best way to track progress

Hinweis der Redaktion

  1. Studies could be:population or industry basedsingle or pooled study meta-analysisSelected studies with comparable exposures to GB:Large sample sizeClear case definitionAppropriate comparison populationControlled for confounders where possibleAdequate exposure assessmentNational data sources used to get the numbers ever exposed. CAREX – CARcinogen Exposure database – gives the estimated numbers exposed by country, carcinogen and industry. Included 139 agents evaluated by IARC as Groups 1,2A and some 2B across 55 industrial classes of the UN system ISIC. However, the prevalences were largely based on US and Finnish (FINJEM) rates and applied to numbers employed in the industry of other countries. LFS series of 2% household based samples from 1973Census of employment etc employer based surveys from 1971 – gives numbers by sex/ full and part time/ 4 digit SIC code.Numbers ever worked from UK population of numbers of working age over the REP – gave denominator for the proportion.Adjusted for turnover, new workers and people retiring and dying + change in broad trends in employment patterns e.g. Service industries going up, manufacturing going downThree international workshops held during the project to discuss and develop the methodology. Helped to focus the assumptions we had to make to take account of inherent limitations in available data. These included:Pragmatic decision about REP and cancer latencyDecision to assign industry sectors to ‘higher’ and ‘lower’ i.e. had proportions exposed over the REP at these two levels and then used published literature to select appropriate risk estimates for these levelsDecision to use IARC group 1 and 2A. NB study carried out using classifications in place at end of 2008. In 2009 IARC reviewed all class 1 carcinogens so if we estimated burden now more cancer sites would be included e.g. asbestos and cervical cancer, colorectal cancer
  2. Example using silica.We know from exposure data that currently compliance to the current limit of 0.1mg/m3 is only about 33%. Table shows the impact of improving compliance compared with lowering a standard.Could vary both of these and the timing of introducing the standard. Can also express this in terms of DALYs which can be fed into economic analysesDecisions can be made on the scenarios, the AFs, ANs, DALYs etc
  3. Right hand graph shows the AFs for each scenario.No difference between them until after 2030Left hand graph shows the same scenarios for each forecast yearShows no difference in attributable cancers between the scenarios up to 2030.Also because the total nos of lung cancers will rise anyway due to the rise population and rising proportion of the elderly the numbers of attributable cancers rises until after 2020.General conclusion is that whatever the intervention there is no impact until after 2030 because of the legacy of past exposures.
  4. This example assumes we have halved the current limit and then tests how effective improving compliance is by workplace size. The most effective interventions are the last 2 when a) compliance improves in those companies employing less than 50 employees (200 more saved compared with previous intervention when compliance is improved in only those companies employing more than 50 employees)b) All workplaces have improved compliance including the self-employed (another 200).This is because silica exposure now occurs largely in the construction industry which is largely small companies and the self-employed.
  5. Will rise to nearly 13,000 by 2060 given current trends in employment and exposure levels (&gt;12,300 if current levels maintained). Aging population is a factor.No impact seen until 2030 because of general increase in cancers due to aging populationWith modest intervention (e.g. scenario 3) over 2,000 cancers can be avoided (including 376 lung, 928 breast cancers, 432 NMSC)With stronger interventions (e.g. scenario 6) nearly 8,500 can be avoided (including 1,732 lung, 3,062 breast and 3,287 NMSC)Effective interventionsSilica - improve complianceDEE - need for v. low exposure limit indicatedShift work – If increasing risk with duration of exposure is valid then limiting years of night work reduces burdenIntervention scenariosETS: Compliance (3) 98% services 90% other (4) 95%/80%Radon: Reduce exposed numbers by 10% in (3) 2010, (4) 2020, (5) 2030, (6) 50% in 2010Solar radiation: Move (3) 1/3, (4) 2/3, (5) all to next lower exposure category resp., (6) move all to lowest exposure categoryShift Work: Restrictions on length of employment result in (3) 20% 30% 50%, (4) 10% 20% 70%, (5) 0% 10% 90%, at 15+ years, 5-14 years and &lt;5 years resp. (6) 100% at &lt;5 yearsFor occupations (and coal tars), excess risk reduced to: (3) 75%, (4) 50%, (5) 25% of current risk in 2010, 2020, 2030 resp., (6) 50% of current risk in 2010For chemicals: (3) = existing (asbestos, RCS) or proposed standard, 90% compliance (4) = half this standard (5) = quarter of standard (except asbestos, DEE where 10%) (6) = existing/proposed standard, 99% compliance (except asbestos, DEE where 1% of standard, 90% compliance)Intervention (3) for the chemical agents represents 90% compliance to an existing (RCS, asbestos) or possible standard, e.g. 0.1 mg/m**3 for DEE based on a standard used in Austria or our estimated H/L boundary exposure levels for arsenic, strong acids and tetrachloroethylene (L/B for TCDD). H/L was chosen as these carcinogens are either genotoxic or possibly genotoxic there is no recognised threshold below which excess risk can be assumed to be zero (background exposed). For the other agents it represents a 25% reduction in RR for the occupations and for coal tars and a modest limit on night shift work from 30% 40% 30% working 15+, 5-14 and &lt;5 years respectively to 20% 30% 50% in these categories. For radon exposed numbers are reduced by 10%, and for solar radiation a third of workers are moved into the next lowest category of time spent outdoors. Together these interventions would avoid over 2,000 cancers a year by 2060, highlighted green are &gt;100.Intervention (6) for the chemical agents represents 99% compliance to an existing (RCS) or possible standard, e.g. our estimated H/L boundary exposure levels for arsenic, strong acids and tetrachloroethylene (L/B for TCDD). For asbestos and DEE where it represents 90% compliance to a stringent 1/100th of the current exposure standard. For the other agents it represents a 50% reduction in RR for the occupations and for coal tars and a limit on night shift work to &lt;5 years duration. For radon exposed numbers are reduced by 50% immediately, and for solar radiation all workers are moved into the lowest category of time spent outdoors. Together these interventions would avoid over 8,000 cancers a year by 2060, highlighted blue are &gt;100.
  6. The method should be used for comparing the effect of alternative interventions, or comparing avoidable numbers of attributable cancers between exposures. NB don’t apply achieved AF to real 2030 cancer numbers as these will have increased because of the increasing proportions of the elderly. Note: there will probably have been many changes in the contribution of other environment and lifestyle risk factors.